ROCKWELL MEDICAL, INC. Debt Securities, Available-for-sale, Unrealized Gain
ROCKWELL MEDICAL, INC. (RMTI) reported Debt Securities, Available-for-sale, Unrealized Gain of $26.40 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain · last filed 2019-11-12
- ROCKWELL MEDICAL, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2019-09-30 was $4.64K.
- ROCKWELL MEDICAL, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2019-06-30 was $14.55K.
- ROCKWELL MEDICAL, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2019-03-31 was $7.21K.
- ROCKWELL MEDICAL, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2018-12-31 was -$79.18K.
- ROCKWELL MEDICAL, INC. debt securities, available-for-sale, unrealized gain for fiscal 2017 was $30.06K.
- ROCKWELL MEDICAL, INC. debt securities, available-for-sale, unrealized gain for fiscal 2015 was $69.88K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain 3 month | Debt Securities, Available-for-sale, Unrealized Gain 6 month | Debt Securities, Available-for-sale, Unrealized Gain 9 month | Debt Securities, Available-for-sale, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2019-09-30 | $4.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $19.19K derived: sum of 2 quarters · filed 2019-11-12 | $26.40K 10-Q · filed 2019-11-12 | -$52.77K derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $14.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $21.76K 10-Q · filed 2019-08-09 | -$57.42K derived: sum of 3 quarters · filed 2019-11-12 | -$57.42K derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-03-31 | $7.21K 10-Q · filed 2019-05-10 | -$71.97K derived: sum of 2 quarters · filed 2019-11-12 | -$71.97K derived: sum of 3 quarters · filed 2019-11-12 | -$71.97K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-12-31 | -$79.18K derived: 10-Q 12 month − 10-Q 9 month · filed 2019-11-12 | -$79.18K derived: sum of 2 quarters · filed 2019-11-12 | -$79.18K derived: sum of 3 quarters · filed 2019-11-12 | $17.41K 10-Q · filed 2019-11-12 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | $96.59K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 | $103.52K 10-Q · filed 2018-08-14 | ||
| 2017-12-31 | -$5.21K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $243.41K derived: sum of 2 quarters · filed 2019-03-18 | $30.06K 10-K · filed 2019-03-18 | |
| 2017-09-30 | $248.63K 10-Q · filed 2018-11-09 | $35.27K 10-Q · filed 2018-11-09 | ||
| 2015-12-31 | $69.88K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |